Prospective Study
Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis

World J Nephrol
10(6):109-121.
Published online Nov 25, 2021.
doi: 10.5527/wjn.v10.i6.109
Abstract (678)
|
Core Tip (629)
|
Article Highlights (710)
|
Full Article (HTML) (2717)
|
Figures (1-4) (273)
|
Tables (1-6) (289)
|
Full Article (PDF)-2537K (366)
|
Audio-315K (7)
|
Peer-Review Report-204K (118)
|
Answering Reviewers-246K (122)
|
Received: 05/09/2021
|
Revised: 08/19/2021
|
Accepted: 09/17/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (10655)
|
Similar Articles (72)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (3)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open